Scinovex
articleTop 1% cited

2012 focused update of the ESC Guidelines for the management of atrial fibrillation

European Heart Journal · 2012 · Vol. 33(21) · pp. 2719–2747

Abstract

Atrial fibrillation; European Society of Cardiology; Guidelines; Anticoagulation; Novel oral anticoagulants; Left atrial appendage occlusion; Rate control; Cardioversion; Rhythm control; Antiarrhythmic drugs; Upstream therapy; Pulmonary vein isolation; Left atrial ablation; Focused update; RANDOMIZED CONTROLLED-TRIAL; HEART RHYTHM ASSOCIATION; NET CLINICAL BENEFIT; RE-LY TRIAL; STROKE RISK STRATIFICATION; ACUTE CORONARY SYNDROME; RADIOFREQUENCY CATHETER ABLATION; ANTIARRHYTHMIC-DRUG THERAPY; ORAL ANTICOAGULANT DRUGS; NORMALIZED RATIO CONTROL

Atrial Fibrillation Management and OutcomesCardiac Arrhythmias and TreatmentsHealth Systems, Economic Evaluations, Quality of LifeMedicineAtrial fibrillationManagement of atrial fibrillationIntensive care medicineCardiology

MeSH terms

Anti-Arrhythmia AgentsAnticoagulantsAtrial FibrillationElectric CountershockHeart FailureHemorrhageHumansThromboembolismCatheter AblationRisk AssessmentAtrial AppendageStrokeEarly DiagnosisTherapeutic Occlusion
Citations
2,889
FWCI
238.33
field-weighted impact
References
203
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

2012 focused update of the ESC Guidelines for the management of atrial fibrillation · Scinovex